• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Noninvasive Electrocardiol . Association between electrocardiographic features and mortality in COVID-19 patients

tetano

Editor, Senior Moderator
Ann Noninvasive Electrocardiol


. 2021 Mar 19;e12833.
doi: 10.1111/anec.12833. Online ahead of print.
Association between electrocardiographic features and mortality in COVID-19 patients


Daniel Antwi-Amoabeng[SUP] 1 [/SUP], Bryce D Beutler[SUP] 1 [/SUP], Sahajpreet Singh[SUP] 1 [/SUP], Moutaz Taha[SUP] 1 [/SUP], Jasmine Ghuman[SUP] 1 [/SUP], Ahmed Hanfy[SUP] 1 [/SUP], Nicholas T Manasewitsch[SUP] 1 [/SUP], Mark B Ulanja[SUP] 1 [/SUP], Joban Ghuman[SUP] 2 [/SUP], Munadel Awad[SUP] 1 [/SUP], Nageshwara Gullapalli[SUP] 1 [/SUP], T David Gbadebo[SUP] 3 [/SUP]



Affiliations

Abstract

Background: Cardiovascular events have been reported in the setting of coronavirus disease-19 (COVID-19). It has been hypothesized that systemic inflammation may aggravate arrhythmias or trigger new-onset conduction abnormalities. However, the specific type and distribution of electrocardiographic disturbances in COVID-19 as well as their influence on mortality remain to be fully characterized.
Methods: Electrocardiograms (ECGs) were obtained from 186 COVID-19-positive patients at a large tertiary care hospital in Northern Nevada. The following arrhythmias were identified by cardiologists: sinus bradycardia, sinus tachycardia, atrial fibrillation (A-Fib), atrial flutter, multifocal atrial tachycardia (MAT), premature atrial contraction (PAC), premature ventricular contraction (PVC), atrioventricular block (AVB), and right bundle branch block (RBBB). The mean PR interval, QRS duration, and corrected QT interval were documented. Fisher's exact test was used to compare the ECG features of patients who died during the hospitalization with those who survived. The influence of ECG features on mortality was assessed with multivariable logistic regression analysis.
Results: A-Fib, atrial flutter, and ST-segment depression were predictive of mortality. In addition, the mean ventricular rate was higher among patients who died as compared to those who survived. The use of therapeutic anticoagulation was associated with reduced odds of death; however, this association did not reach statistical significance.
Conclusion: The underlying pathogenesis of COVID-19-associated arrhythmias remains to be established, but we postulate that systemic inflammation and/or hypoxia may induce potentially lethal conduction abnormalities in affected individuals. Longitudinal studies are warranted to evaluate the risk factors, pathogenesis, and management of COVID-19-associated cardiac arrhythmias.

Keywords: A-Fib; COVID-19; atrial fibrillation; cardiac arrhythmias; coronavirus disease-19; electrocardiogram.
 
Back
Top Bottom